Drug Discovery Partnership Conference
| October 28, 2009 | to | October 30, 2009 |
By Opal Group
Location: Hyatt Regency Boston
The conference is designed specifically to discuss and debate new partnership models between Academia and Industry, and to solidify strategies in integrating early stage drug discovery projects.
This three-day conference will kick off with a pre-conference workshop day on Oct 28th; follow by the main sessions on Oct 29th & 30th to discuss possibilities in academia-industrial partnership, strategic alliance, and partnerships/opportunities showcase etc. Networking activities throughout the event will allow you to get in front of potential partners and ensure you can increase your positional strength in this volatile market.
Some of the topics to be covered include: Valuation and pricing for early-stage technologies; Licensing/ Patenting/ IP Issues; Funding for start-up; NIH Roadmap; Technical integration and Eli Lilly’s Phenotypic Drug Discovery (PD2) Initiative.
Registration for the first 100 Pharma/Biotech, Academia, and Government representatives is FREE. Please contact Judy Sin at kye@opalevents.org for registration.
For more information about the conference please visit www.opalevents.org.